Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Leukocyte Telomere Length in Patients with Multiple Sclerosis and Its Association with Clinical Phenotypes
Michael Hecker, Brit Fitzner, Kathrin Jäger, et al.
Molecular Neurobiology (2021) Vol. 58, Iss. 6, pp. 2886-2896
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Ageing and multiple sclerosis
Jennifer Graves, Kristen M. Krysko, Le H. Hua, et al.
The Lancet Neurology (2022) Vol. 22, Iss. 1, pp. 66-77
Open Access | Times Cited: 121
Therapeutic Advances in Multiple Sclerosis
Jennifer H. Yang, Torge Rempe, Natalie Whitmire, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 89
Molecular Mechanisms of Immunosenescene and Inflammaging: Relevance to the Immunopathogenesis and Treatment of Multiple Sclerosis
Océane Perdaens, Vincent Van Pesch
Frontiers in Neurology (2022) Vol. 12
Open Access | Times Cited: 40
Immunosenescence and multiple sclerosis: inflammaging for prognosis and therapeutic consideration
Smathorn Thakolwiboon, Elizabeth Mills, Jennifer Yang, et al.
Frontiers in Aging (2023) Vol. 4
Open Access | Times Cited: 20
Mechanistic underpinning of an inside–out concept for autoimmunity in multiple sclerosis
Bert A. ‘t Hart, Antonio Luchicchi, Geert J. Schenk, et al.
Annals of Clinical and Translational Neurology (2021) Vol. 8, Iss. 8, pp. 1709-1719
Open Access | Times Cited: 35
A causal relationship between leukocyte telomere length and multiple sclerosis: A Mendelian randomization study
Qiao Liao, Jian He, Fafa Tian, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 26
Systematic Review of Studies on Telomere Length in Patients with Multiple Sclerosis
Jan Bühring, Michael Hecker, Brit Fitzner, et al.
Aging and Disease (2021) Vol. 12, Iss. 5, pp. 1272-1272
Open Access | Times Cited: 29
Genetic, Environmental and Lifestyle Determinants of Accelerated Telomere Attrition as Contributors to Risk and Severity of Multiple Sclerosis
Michael Hecker, Jan Bühring, Brit Fitzner, et al.
Biomolecules (2021) Vol. 11, Iss. 10, pp. 1510-1510
Open Access | Times Cited: 29
A Review of Telomere Attrition in Cancer and Aging: Current Molecular Insights and Future Therapeutic Approaches
Mina Iskandar, M. Barbéro, Mohammed Tariq Jaber, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 257-257
Open Access
Deciphering the Bidirectional Impact of Leukocyte Telomere Length on Multiple Sclerosis Progression: A Mendelian Randomization Study
Hani Sabaie, Ali Taghavi Rad, Mahnaz Sadeghi‐Shabestari, et al.
Multiple Sclerosis and Related Disorders (2025) Vol. 94, pp. 106277-106277
Closed Access
Cellular Senescence in Glial Cells: Implications for Multiple Sclerosis
Elizabeth A. Maupin, Katrina L. Adams
Journal of Neurochemistry (2025) Vol. 169, Iss. 1
Open Access
Senescence marker p16INK4a expression in patients with multiple sclerosis
Jennifer H. Yang, Annalise E. Miner, Ashley Fair, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 84, pp. 105498-105498
Open Access | Times Cited: 3
The Impact of Aging on Multiple Sclerosis
Christopher E. Goyne, Ashley Fair, Paige E. Sumowski, et al.
Current Neurology and Neuroscience Reports (2024) Vol. 24, Iss. 4, pp. 83-93
Closed Access | Times Cited: 3
Multiple sclerosis and drug discovery: A work of translation
Bert A. ‘t Hart, Antonio Luchicchi, Geert J. Schenk, et al.
EBioMedicine (2021) Vol. 68, pp. 103392-103392
Open Access | Times Cited: 18
Immunosenescence and multiple sclerosis
Monika Adamczyk‐Sowa, Maria Nowak, Jerzy Jaroszewicz, et al.
Neurologia i Neurochirurgia Polska (2022) Vol. 56, Iss. 3, pp. 220-227
Open Access | Times Cited: 11
Potential roles of telomeres and telomerase in neurodegenerative diseases
Jun Shao, Jing Wang, Bo Li, et al.
Ageing and Neurodegenerative Diseases (2024) Vol. 4, Iss. 1
Open Access | Times Cited: 2
The influence of aging and the microbiome in multiple sclerosis and other neurologic diseases
Naomi M. Fettig, Annie Pu, Lisa C. Osborne, et al.
Immunological Reviews (2024) Vol. 325, Iss. 1, pp. 166-189
Closed Access | Times Cited: 1
X-linked genetic risk factors that promote autoimmunity and dampen remyelination are associated with multiple sclerosis susceptibility
Kirill Borziak, Joseph Finkelstein
Multiple Sclerosis and Related Disorders (2022) Vol. 66, pp. 104065-104065
Closed Access | Times Cited: 7
Genetically predicted telomere length and multiple sclerosis
Mei-Jun Shu, Jiarui Li, Yi‐Cheng Zhu
Multiple Sclerosis and Related Disorders (2022) Vol. 60, pp. 103731-103731
Closed Access | Times Cited: 6
Immunosenescence in Neurological Diseases—Is There Enough Evidence?
Paulus Rommer, Gabriel Bsteh, Tobias Zrzavy, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2864-2864
Open Access | Times Cited: 6
Susceptibility networks reveal independent patterns of brain iron abnormalities in multiple sclerosis
Jack A. Reeves, Niels Bergsland, Michael G. Dwyer, et al.
NeuroImage (2022) Vol. 261, pp. 119503-119503
Open Access | Times Cited: 4
Leukocyte telomere length in multiple sclerosis: relationship between disability severity and pregnancy history
Michael Zhong, Sabrina Salberg, Sandeep Sampangi, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 86, pp. 105607-105607
Open Access
A Natural Astragalus-Based Nutritional Supplement Lengthens Telomeres in a Middle-Aged Population: A Randomized, Double-Blind, Placebo-Controlled Study
Christophe de Jaeger, Saskia Kruiskamp, Elena Voronska, et al.
Nutrients (2024) Vol. 16, Iss. 17, pp. 2963-2963
Open Access
Telomere length as a biomarker in multiple sclerosis
María Agustina Piedrabuena, Jorge Correale, Mauricio Farez, et al.
Multiple Sclerosis Journal (2024) Vol. 30, Iss. 10, pp. 1258-1267
Closed Access
Review of evidence linking exposure to environmental stressors and associated alterations in the dynamics of immunosenescence (ISC) with the global increase in multiple sclerosis (MS)
C. Bolton
Immunity & Ageing (2024) Vol. 21, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top